Ignite Creation Date:
2024-05-06 @ 8:21 PM
Last Modification Date:
2024-10-26 @ 3:26 PM
Study NCT ID:
NCT06351891
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-04-08
First Post:
2024-04-02
Brief Title:
Efficacy and Safety of Bismuth Quadruple Therapy Containing Cefuroxime and Tetracycline as First-line Therapy for Eradicating Helicobacter Pylori in Patients Allergic to Penicillin
Sponsor:
Qilu Hospital of Shandong University
Organization:
Qilu Hospital of Shandong University
Organization Data
Organization:
Qilu Hospital of Shandong University
Class:
OTHER
Study ID:
SHARE2402
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Qilu Hospital of Shandong University
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None